SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029125
Filing Date
2023-08-16
Accepted
2023-08-16 14:11:23
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1365253
2 ex10-3.htm EX-10.3 27984
3 ex31-1.htm EX-31.1 9572
4 ex31-2.htm EX-31.2 9595
5 ex32-1.htm EX-32.1 4153
6 ex32-2.htm EX-32.2 4167
  Complete submission text file 0001493152-23-029125.txt   4999240

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rnxt-20230630.xsd EX-101.SCH 33723
8 XBRL CALCULATION FILE rnxt-20230630_cal.xml EX-101.CAL 38452
9 XBRL DEFINITION FILE rnxt-20230630_def.xml EX-101.DEF 120172
10 XBRL LABEL FILE rnxt-20230630_lab.xml EX-101.LAB 298076
11 XBRL PRESENTATION FILE rnxt-20230630_pre.xml EX-101.PRE 223168
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 646521
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 231177763
SIC: 2834 Pharmaceutical Preparations